{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019760","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2022-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.218615+00:00","generated_at":"2026-06-24T12:19:44.621939+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"RenovoRx names James Ahlers CFO, Chris Lehman resigns; Ronald Kocak added as VP/Controller","bullets":["CFO Christopher Lehman resigned effective July 15, 2022 to pursue a new opportunity.","James Ahlers appointed CFO, Secretary and Treasurer effective July 15, 2022; will serve as principal financial and accounting officer.","Ahlers is a consultant from Danforth Advisors; RenovoRx pays Danforth $450/hour for his services.","Ronald B. Kocak, CPA, appointed VP and Controller; previously served as interim controller since October 2021.","Ahlers has over 25 years life science finance experience, including CFO of Intarcia Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019760","json":"https://secwatch.observer/filing/0001493152-22-019760.json","markdown":"https://secwatch.observer/filing/0001493152-22-019760.md","text":"https://secwatch.observer/filing/0001493152-22-019760.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/0001493152-22-019760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T12:19:44.621939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83844b62a6","claim":"James Ahlers was appointed as Chief Financial Officer, Secretary and Treasurer at RenovoRx, Inc..","evidence_excerpt":"The Company’s Board of Directors has appointed Mr. James Ahlers, age 58, as Chief Financial Officer, Secretary and Treasurer, as of July 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/0001493152-22-019760-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer, Secretary and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"8df097786a","claim":"Christopher J. Lehman resigned as Chief Financial Officer at RenovoRx, Inc..","evidence_excerpt":"Christopher J. Lehman notified RenovoRx, Inc. (the “Company”) of his decision to resign as Chief Financial Officer, effective July 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/0001493152-22-019760-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}